In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results and Research Summary: https://t.co/k3fRIyyFpd https://t.co/KvL8xLJQ14
Colchicine in Acute Myocardial Infarction.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2024 – Nov 2025Where it's discussed
-
X / Twitter140 posts
-
Bluesky7 posts
-
YouTube6 videos
-
News6 articles
-
Facebook3 posts
-
Blogs3 articles
AI synopsis
What people are saying
Several discussions highlight the trial results, such as mentions that colchicine did not significantly reduce major cardiovascular events despite lowering inflammation markers, while others debate the significance of these findings for future treatments. The tone combines cautious acknowledgment of the data with skepticism about its clinical impact, reflecting moderate engagement and interest.
Discussions show mixed opinions, with some posts acknowledging the trial's findings and others questioning the inflammatory hypothesis.
Moderate interest is evident as posts focus on trial results and implications for treatment, but lack strong enthusiasm.
Posts reference specific results and studies, indicating some critical engagement, but not deeply analytical.
The overall tone suggests recognition of the trial's importance but also highlights ongoing controversy, leading to a neutral impact assessment.
Abstract in brief
- * A total of 7062 patients participated, and the results showed no significant difference in primary cardiovascular outcomes between the colchicine group (9.1%) and the placebo group (9.3%) over a 3-year follow-up period.
- * Colchicine did lower C-reactive protein levels, indicating some anti-inflammatory effect, but it also caused more diarrhea compared to placebo, though serious infections were similar in both groups.
Top posts
Most liked on X and BlueskyNew in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Routine Spironolactone in Acute Myocardial Infarction (CLEAR trial) https://t.co/YiRtIHAv2u Cabozantinib in Advanced Neuroendocrine Tumors (CABINET https://t.co/vKMrPRVXiH
Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming of Vascular Inflammation https://t.co/CaMmhgLAEP #Cardiology https://t.co/uumDxa9cdu
Colchicine in Acute Myocardial Infarction
#Colchicine in Acute Myocardial Infarction www.nejm.org/doi/full/10.... #AHA24 #NEJM #CardioSky #MedSky @ahascience.bsky.social
In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results and Research Summary: nej.md/4i2U6dV #MedSky #CardioSky
All mentions
Evaluating the Effectiveness of Colchicine in Reducing Cardiovascular Events Post-Myocardial Infarction
The study investigated whether colchicine reduces cardiovascular events in patients who had a myocardial infarction compared to a placebo. Results showed no significant difference in primary cardiovascular outcomes over…
Evaluating the Impact of Anti-Inflammatory Treatment on Heart Disease Risk
This study investigated whether colchicine reduces cardiovascular events in patients who had a myocardial infarction, finding no significant difference in primary outcomes despite lowering C-reactive protein levels.
Evaluating Colchicine's Effectiveness in Reducing Cardiovascular Events Post-Myocardial Infarction
This study examines whether colchicine reduces cardiovascular events in patients after myocardial infarction. Results showed no significant difference in primary outcomes between colchicine and placebo groups over 3…
Remnant Cholesterol and Cardiovascular Risk in Chronic Kidney Disease
Prof Borge Nordestgaard discusses the significance of remnant cholesterol in atherosclerotic cardiovascular disease, focusing on patients with chronic kidney disease and recent epidemiological data from the Copenhagen…
Key Insights from Recent Cardiovascular Trials and Colchicine Study
This week in cardiology, we review recent clinical trials including OPTION, SUMMIT, and VANISH, with focus on AF management, heart failure, and infarction treatments. The Colchicine study shows no significant reduction…
Colchicine's Limited Effect in Preventing Cardiac Events Post-Heart Attack
The study examined whether colchicine reduces cardiovascular events after myocardial infarction. Results showed no significant difference in primary outcomes between colchicine and placebo groups over 3 years, despite…
دراسة CLEAR SYNERGY السلبيه https://t.co/51YpGJ0MFR
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
Dr. Wedyan Alhrabi, R1 Clinical Pharmacy Resident presented a journal club on “ Colchicine in Acute Myocardial Infarction.” Thank you for a thought-provoking and insightful discussion!
This Cheap Anti-inflammatory Cuts Heart Disease by 12% https://t.co/H0srndgq2r via @YouTube
RT @irjpnmEqqEUJraX: CLEAR trial NEJM2024 STEMI/NSTEMIでPCI直後7062例を対象にした2-by-2 factorial design RCT。中央値3年追跡後、コルヒチンはCRPを有意に低下させたが、心血管死亡、心不全、…
Colchicine in Acute Myocardial Infarction https://t.co/p7leYvjlIb
A study found that long-term low-dose colchicine did not reduce heart event risks after a heart attack, though it decreased inflammation. More diarrhea occurred with colchicine. This differs from past studies on stable heart disease. Read more: https://t.co/qhmhTtVHdi
@drandrewsharp @BudoffMd @ACCinTouch I guess you mean that these trials mean that blocking inflammation is no longer valid Andrew
Colchicine cuts cardiovascular deaths and events in MI by 23%! In a 2x2 trial, MI patients on colchicine show notable benefits. Exciting cardioprotective potential! #CardioDiscovery PMID:39555823, N Engl J Med 2025, @NEJM https://doi.org/10.1056/NEJMoa2405922 #Medsky #Pharmsky #RNAsky
Colchicina en el infarto agudo de miocardio https://t.co/tWXxhXo4jx PMID 39555823
Colchicine treatment after myocardial infarction did not significantly reduce cardiovascular events compared to placebo in a large trial. by Jolly SS, d'Entremont MA (...) Yusuf S et 25 al. in N Engl J Med #MedSky
Colchicine treatment after myocardial infarction did not significantly reduce cardiovascular events compared to placebo in a large trial. by Jolly SS, d'Entremont MA (...) Yusuf S et 25 al. in N Engl J Med https://t.co/bEKdXRu72v #MedX #MedResearch
Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/pHRhHLhLNZ ....Goodbye Colchicine
Why was COLCOT +pos, but CLEAR -neg.. I typically consider colchicine in post-MI with elevated hsCRP > 2.0 when LDL is at goal. @NEJM @drjohnm https://t.co/sEE1mq0RUz
RT @DrDamluji: Colchicine in Acute Myocardial Infarction: @NEJM
Colchicine cuts cardiovascular deaths and events in MI by 23%! In a 2x2 trial, MI patients on colchicine show notable benefits. Exciting cardioprotective potential! #CardioDiscovery PMID:39555823, N Engl J Med 2025, @NEJM https://t.co/BCiAGkyuH7
RT @ZHeart11768530:
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
Colchicine in Acute Myocardial Infarction https://t.co/tKLyGJT3G3
Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/obMvPj1cTr
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results and Research Summary: nej.md/4i2U6dV #MedSky #CardioSky
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
References: 1. Jolly, S.S., d’Entremont, M.A., Lee, S.F., Mian, R., Tyrwhitt, J., Kedev, S., Montalescot, G., et al. (2025) 'Colchicine in Acute Myocardial Infarction', New England Journal of Medicine. 392(7):633-642. 2. González, L., Bulnes, J.F., Orellana, M.P., Venturelli,
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
RT @NEJM: In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse car…
In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results and Research Summary: https://t.co/k3fRIyyFpd https://t.co/KvL8xLJQ14
No effect of colchicine on death from AMI. It remains controversial. https://t.co/M5nPciwFBg
Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/XHNaJ9L8O0
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @GlobalPHObserv: Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/kucOdoGZJG
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
Que yo sepa, miles de Colegas se "engancharon" con el supuesto efecto benéfico de la #Colchicina en el #IAM alla por los ´70 u ´80. Dejen de jorobar de una buena vez, #NOSIRVEPARANADA: https://t.co/7tsVf93Rqe
RT @PabloPerezMar16: Habrá que esperar a los resultados de los ensayos de las moléculas que inhiben específicamente Il-6 para confirmar o d…
Habrá que esperar a los resultados de los ensayos de las moléculas que inhiben específicamente Il-6 para confirmar o desterrar la hipótesis inflamatoria!!!Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/qQOkeLn1oN
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @GlobalPHObserv: Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/kucOdoGZJG
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @cpgale3: Diarrhoea was the only difference: colchicine in acute #heartattack @NEJM https://t.co/mZF5rbiVh3
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/zgESzU905E
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming…
Diarrhoea was the only difference: colchicine in acute #heartattack @NEJM https://t.co/mZF5rbiVh3
Original Article: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Editorial: Timing the Taming of Vascular Inflammation https://t.co/CaMmhgLAEP #Cardiology https://t.co/uumDxa9cdu
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
CLEAR trial (colchicine arm): In Pts with acute MI (mostly STEMI) who underwent PCI, colchicine 0.5 mg daily did not ⬇️MACE vs. placebo at 3 years. https://t.co/VyZQWW1Awy https://t.co/JtBH4B3BXW
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
“Colchicine in Acute Myocardial Infarction.” Publié ce jour dans le @nejm.org. #Medsky #Cardiology www.nejm.org/doi/full/10....
RT @NEJM: New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd…
New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) nej.md/4i2U6dV Routine Spironolactone in Acute Myocardial Infarction (CLEAR trial) nej.md/4ftkpIc Cabozantinib in Advanced Neuroendocrine Tumors (CABINET trial) nej.md/3AYuEoI #MedSky
New in the February 13, 2025, issue of NEJM: Colchicine in Acute Myocardial Infarction (CLEAR trial) https://t.co/k3fRIyyFpd Routine Spironolactone in Acute Myocardial Infarction (CLEAR trial) https://t.co/YiRtIHAv2u Cabozantinib in Advanced Neuroendocrine Tumors (CABINET https://t.co/vKMrPRVXiH
Colchicine in Acute Myocardial Infarction https://t.co/80UQMbmB70
RT @rubencotoh: Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/WRRk8KtuiY Hay partido @SilviaP…
RT @rubencotoh: Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/WRRk8KtuiY Hay partido @SilviaP…
RT @rubencotoh: Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/WRRk8KtuiY Hay partido @SilviaP…
Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/WRRk8KtuiY Hay partido @SilviaPorto88 @caminalm
RT @GlobalPHObserv: Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/kucOdoGZJG
Journal Club Review: Colchicine in Acute Myocardial Infarction https://t.co/csLrSFeZVZ
Journal Club Review: Colchicine in Acute Myocardial Infarction https://t.co/csLrSFeZVZ
Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/kucOdoGZJG
Join us as Dr. Jung-In Choi presents the CLEAR SYNERGY Trial: Colchicine Arm, a multi-centre, investigator-initiated, randomized placebo-controlled trial using a 2x2 factorial design to assess colchicine in acute myocardial infarction. Thu, February 6 @ 4:00 p.m. #cardiovascular https://t.co/LJCHgxf3BD
RT @cardio_tu: 2 min cardiology(臨床、担当:粕壁幸恵) Colchicine in Acute Myocardial Infarction S S Jolly et al. NEJM Nov 17, 2024. https://t.co/L…
2 min cardiology(臨床、担当:粕壁幸恵) Colchicine in Acute Myocardial Infarction S S Jolly et al. NEJM Nov 17, 2024. https://t.co/LvxGu5NV6z 急性心筋梗塞患者を対象とした本試験では、心筋梗塞直後に治療を開始し中央値3年間継続したコルヒチン治療は、 →
RT @drbennisahmed: Top 10 Clinical Trials ACC 2024 Colchicine in Acute Myocardial Infarction Among patients who had MI treatment with c…
Top 10 Clinical Trials ACC 2024 Colchicine in Acute Myocardial Infarction Among patients who had MI treatment with colchicine, started soon after MI and continued for a median of 3 years, did not reduce the incidence of the composite primary outcome https://t.co/ojvsmyWcyi
Colchicine in Acute Myocardial Infarction - PubMed https://t.co/gm3NhtRW8C
Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/FCoduH10wK Pese a la hipótesis inicial, la Colchicina en el IAM no reduce la mortalidad cardiovascular, ni el reinfarto
コルヒチンもダメだったのか https://t.co/UxByq0ZGaw
Colchicine treatment post-myocardial infarction showed no significant impact on major cardiovascular events, despite reducing inflammation markers. by Jolly SS, d'Entremont MA (...) Bossard M et 11 al. in N Engl J Med https://t.co/bEKdXRtzcX
【RCT】心筋梗塞患者へのコルヒチンの投与は、プラセボの投与と比較して、心血管死亡、心筋梗塞再発、脳卒中、予定外の虚血による冠血行再建のリスクを減少させなかった。 #ペ読 https://t.co/W5nkN4XBxy
RT @MohammedAlo: Colchicine in Acute Myocardial Infarction
RT @MohammedAlo: Colchicine in Acute Myocardial Infarction
Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/15OTJvvFJI
RT @MohammedAlo: Colchicine in Acute Myocardial Infarction
RT @MohammedAlo: Colchicine in Acute Myocardial Infarction
Colchicine in Acute Myocardial Infarction
心筋梗塞早期のコルヒチン投与、有効性示せず Colchicine in Acute Myocardial Infarction | New England Journal of Medicine https://t.co/EjawX4E5W1
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR) https://t.co/k3fRIyyFpd #Cardiology https://t.co/yaPRpJEA2v
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR) https://t.co/k3fRIyyFpd #Cardiology https://t.co/yaPRpJEA2v
RT @DrDamluji: Colchicine in Acute Myocardial Infarction: @NEJM
RT @NEJM: Original Article: Colchicine in Acute Myocardial Infarction (CLEAR) https://t.co/k3fRIyyFpd #Cardiology https://t.co/yaPRpJEA2v
Colchicine in Acute Myocardial Infarction - Did not reduce the incidence of the composite primary outcome (death from cardiovascular causes, recurrent myocardial infarction, stroke, or unplanned ischemia-driven coronary revascularization). www.nejm.org/doi/full/10....
#Colchicine in Acute Myocardial Infarction www.nejm.org/doi/full/10.... #AHA24 #NEJM #CardioSky #MedSky @ahascience.bsky.social
أا
TG
W